OTCMKTS:RHHBY - Roche Holdings AG Basel Stock Price, Forecast & News

Roche Holdings AG Basel trades on the OTCMKTS under the ticker symbol "RHHBY."

6 brokers have issued 12-month price targets for Roche Holdings AG Basel's stock. Their forecasts range from $48.00 to $48.00. On average, they expect Roche Holdings AG Basel's share price to reach $48.00 in the next year. This suggests a possible upside of 8.9% from the stock's current price. View Analyst Price Targets for Roche Holdings AG Basel.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche Holdings AG Basel in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Roche Holdings AG Basel.

Press coverage about RHHBY stock has been trending very negative on Wednesday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Roche Holdings AG Basel earned a media sentiment score of -3.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Roche Holdings AG Basel.

Some companies that are related to Roche Holdings AG Basel include Johnson & Johnson (JNJ), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AbbVie (ABBV), Eli Lilly And Co (LLY), AstraZeneca (AZN), Sanofi (SNY), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Commonwealth Bank of Australia (CSLLY), Celgene (CELG) and Bayer (BAYRY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Roche Holdings AG Basel investors own include Roche Holding Ltd. Genussscheine (ROG), Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), General Electric (GE), Merck & Co., Inc. (MRK), Novartis (NVS) and Walt Disney (DIS).

Roche Holdings AG Basel's stock is owned by many different of retail and institutional investors. Top institutional investors include Mairs & Power INC (0.08%), Schafer Cullen Capital Management Inc (0.02%), Bowen Hanes & Co. Inc. (0.01%), Douglass Winthrop Advisors LLC (0.01%), Riverbridge Partners LLC (0.01%) and Boston Common Asset Management LLC (0.01%).

RHHBY stock was sold by a variety of institutional investors in the last quarter, including Schafer Cullen Capital Management Inc, Valicenti Advisory Services Inc., Chartwell Investment Partners LLC, Pacer Advisors Inc., Kornitzer Capital Management Inc. KS, Canandaigua National Bank & Trust Co., Osher Van de Voorde Investment Management and Oxbow Advisors LLC.

RHHBY stock was purchased by a variety of institutional investors in the last quarter, including Bowen Hanes & Co. Inc., Wallington Asset Management LLC, Anderson Hoagland & Co., Mairs & Power INC, Ancora Advisors LLC, Tocqueville Asset Management L.P., MAI Capital Management and Ferguson Wellman Capital Management Inc..

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RHHBY stock can currently be purchased for approximately $44.10.

Roche Holdings AG Basel has a market capitalization of $301.98 billion and generates $61.87 billion in revenue each year. The company earns $13.58 billion in net income (profit) each year or $2.54 on an earnings per share basis. Roche Holdings AG Basel employs 97,735 workers across the globe.View Additional Information About Roche Holdings AG Basel.

The official website for Roche Holdings AG Basel is http://www.roche.com/.

Roche Holdings AG Basel's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at 41-61-688-1111 or via email at [email protected]